Albireo: Ipsen extends expiration date of tender offer for Albireo Pharma, Inc. to 1 March 2023

Ipsen S.A. announced that Anemone Acquisition Corp., its wholly owned indirect subsidiary, has extended the expiration time for the previously announced tender offer to purchase all of the issued and outstanding shares of common stock of Albireo Pharma, Inc. at a price of $42.00 per share.